|
FY2026
12 months to Apr 30, 2026
|
FY2025
12 months to Apr 30, 2025
|
FY2024
12 months to Apr 30, 2024
|
FY2023
12 months to Apr 30, 2023
|
FY2022
12 months to Apr 30, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of products sold | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Operating earnings | |||||
| Pension expense | |||||
| Other income, net | |||||
| Interest expense | |||||
| Total earnings before income tax expense | |||||
| Income tax expense | |||||
| Net earnings | |||||
| Less: net earnings attributable to the non-controlling interest | |||||
| Net earnings attributable to Kewaunee Scientific Corporation | |||||
| Net earnings per share attributable to Kewaunee Scientific Corporation stockholders | |||||
| Basic (in usd per share) | |||||
| Diluted (in usd per share) | |||||
| Weighted average number of common shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
